By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cerimon Pharmaceuticals, Inc. 

701 Gateway Boulevard
Suite 100
South San Francisco  California  94080  U.S.A.
Phone: 650-827-4000 Fax: 650-827-4040


SEARCH JOBS



Segment
Start Up





Company News
Cerimon Pharmaceuticals, Inc. Acquires European Rights to its Topical Diclofenac Sodium Patch 11/10/2009 6:15:39 AM
Cerimon Pharmaceuticals, Inc. Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain 2/25/2009 9:07:47 AM
Cerimon Pharmaceuticals, Inc. Appoints James S. Shannon, M.D., to Board of Directors 12/2/2008 10:16:27 AM
Cerimon Pharmaceuticals, Inc. Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain 9/11/2008 6:35:32 AM
Cerimon Pharmaceuticals, Inc. Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis 7/9/2008 7:58:16 AM
Cerimon Pharmaceuticals, Inc. to Conduct a Proof of Concept Study for Basiliximab for Noninfectious Uveitis, a Potentially Sight-Threatening Inflammation of the Eye 3/10/2008 8:01:01 AM
Cerimon Pharmaceuticals, Inc. Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain 1/16/2008 7:18:12 AM
Cerimon Pharmaceuticals, Inc. Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing 1/4/2008 8:24:34 AM
Cerimon Pharmaceuticals, Inc. to Present at the 2007 Biotechnology Industry Organization (BIO) Investor Forum 10/5/2007 10:11:19 AM
Cerimon Pharmaceuticals, Inc. Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 10/2/2007 8:11:16 AM
123
//-->